These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 31641031)
1. Suppression of LIM Kinase 1 and LIM Kinase 2 Limits Glioblastoma Invasion. Chen J; Ananthanarayanan B; Springer KS; Wolf KJ; Sheyman SM; Tran VD; Kumar S Cancer Res; 2020 Jan; 80(1):69-78. PubMed ID: 31641031 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional profiling of GBM invasion genes identifies effective inhibitors of the LIM kinase-Cofilin pathway. Park JB; Agnihotri S; Golbourn B; Bertrand KC; Luck A; Sabha N; Smith CA; Byron S; Zadeh G; Croul S; Berens M; Rutka JT Oncotarget; 2014 Oct; 5(19):9382-95. PubMed ID: 25237832 [TBL] [Abstract][Full Text] [Related]
3. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma. Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002 [TBL] [Abstract][Full Text] [Related]
4. A dual aurora and lim kinase inhibitor reduces glioblastoma proliferation and invasion. Rybin MJ; Laverde-Paz MJ; Suter RK; Affer M; Ayad NG; Feng Y; Zeier Z Bioorg Med Chem Lett; 2022 Apr; 61():128614. PubMed ID: 35151865 [TBL] [Abstract][Full Text] [Related]
5. LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells. Vlecken DH; Bagowski CP Zebrafish; 2009 Dec; 6(4):433-9. PubMed ID: 20047470 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients. Safaee M; Clark AJ; Oh MC; Ivan ME; Bloch O; Kaur G; Sun MZ; Kim JM; Oh T; Berger MS; Parsa AT PLoS One; 2013; 8(4):e62765. PubMed ID: 23658650 [TBL] [Abstract][Full Text] [Related]
7. Chronophin regulates active vitamin B6 levels and transcriptomic features of glioblastoma cell lines cultured under non-adherent, serum-free conditions. Schulze M; Hutterer M; Sabo A; Hoja S; Lorenz J; Rothhammer-Hampl T; Herold-Mende C; Floßbach L; Monoranu C; Riemenschneider MJ BMC Cancer; 2018 May; 18(1):524. PubMed ID: 29724193 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of LIMK1 level inhibits migration of lung cancer cells and enhances sensitivity to chemotherapy drugs. Chen Q; Jiao D; Hu H; Song J; Yan J; Wu L; Xu LQ Oncol Res; 2013; 20(11):491-8. PubMed ID: 24063279 [TBL] [Abstract][Full Text] [Related]
9. Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression. McConnell BV; Koto K; Gutierrez-Hartmann A Mol Cancer; 2011 Jun; 10():75. PubMed ID: 21682918 [TBL] [Abstract][Full Text] [Related]
10. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion. Zhou Y; Su J; Shi L; Liao Q; Su Q Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092 [TBL] [Abstract][Full Text] [Related]
11. Suppression of the invasive capacity of rat ascites hepatoma cells by knockdown of Slingshot or LIM kinase. Horita Y; Ohashi K; Mukai M; Inoue M; Mizuno K J Biol Chem; 2008 Mar; 283(10):6013-21. PubMed ID: 18171679 [TBL] [Abstract][Full Text] [Related]
12. Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer. Su B; Su J; Zeng Y; Liu F; Xia H; Ma YH; Zhou ZG; Zhang S; Yang BM; Wu YH; Zeng X; Ai XH; Ling H; Jiang H; Su Q Oncotarget; 2016 Mar; 7(9):10498-512. PubMed ID: 26871290 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1. Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963 [TBL] [Abstract][Full Text] [Related]
14. In vitro inhibitory properties of sesquiterpenes from Chloranthus serratus on cell motility via down-regulation of LIMK1 activation in human breast cancer. Fu J; Yu J; Chen J; Xu H; Luo Y; Lu H Phytomedicine; 2018 Oct; 49():23-31. PubMed ID: 30217259 [TBL] [Abstract][Full Text] [Related]
15. LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in mice. Li R; Doherty J; Antonipillai J; Chen S; Devlin M; Visser K; Baell J; Street I; Anderson RL; Bernard O Clin Exp Metastasis; 2013 Apr; 30(4):483-95. PubMed ID: 23239465 [TBL] [Abstract][Full Text] [Related]
16. Correlation between Rho-kinase pathway gene expressions and development and progression of glioblastoma multiforme. Erkutlu I; Cigiloglu A; Kalender ME; Alptekin M; Demiryurek AT; Suner A; Ozkaya E; Ulasli M; Camci C Tumour Biol; 2013 Apr; 34(2):1139-44. PubMed ID: 23338717 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer. Su J; Zhou Y; Pan Z; Shi L; Yang J; Liao A; Liao Q; Su Q Sci Rep; 2017 Mar; 7():45624. PubMed ID: 28358024 [TBL] [Abstract][Full Text] [Related]
18. B7-H3 promotes the migration and invasion of colorectal cancer cells via regulating the actin cytoskeleton and RhoA/ROCK1/LIMK1 signaling pathway. Zhao A; Zhu X; Wu H; Wang J; Zhang M; Xiang J; Xia S; Shi T; Xi Q Tissue Cell; 2024 Oct; 90():102518. PubMed ID: 39173456 [TBL] [Abstract][Full Text] [Related]
19. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression. Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914 [TBL] [Abstract][Full Text] [Related]
20. LIM kinase1 modulates function of membrane type matrix metalloproteinase 1: implication in invasion of prostate cancer cells. Tapia T; Ottman R; Chakrabarti R Mol Cancer; 2011 Jan; 10():6. PubMed ID: 21219645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]